Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Grah

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Evidence-Based Complementary and Alternative Medicine : Ecam|May 27, 2020
Health-Related Quality of Life in Patients with Lung Cancer Applying Integrative Oncology Concepts in a Certified Cancer CentreAnja Thronicke, Phillipp von Trott, Matthias Kröz, et al.
The Thoracic and Cardiovascular Surgeon|February 18, 2021
Is Adjuvant Radiochemotherapy Always Mandatory in Patients with Resected N2 Non-Small Cell Lung Cancer?Samantha Taber, Joachim Pfannschmidt, Torsten T Bauer, et al.
International Journal of Molecular Sciences|May 7, 2025
Combined Immune Checkpoint Blockade and Helixor<sup>®</sup> Therapy in Oncology: Real-World Tolerability and Subgroup Survival (ESMO GROW)Anja Thronicke, Patricia Grabowski, Juliane Roos, et al.
Plos One|August 28, 2018
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysisFriedemann Schad, Anja Thronicke, Megan L Steele, et al.
Plos One|August 16, 2022
Correction: Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysisFriedemann Schad, Anja Thronicke, Megan L Steele, et al.
Plos One|July 28, 2020
Cost-effectiveness of real-world administration of chemotherapy and add-on Viscum album L. therapy compared to chemotherapy in the treatment of stage IV NSCLC patientsAnja Thronicke, Thomas Reinhold, Philipp von Trott, et al.
Respiration; International Review of Thoracic Diseases|March 23, 2020
Endoscopic Lung Volume Reduction: Can Endobronchial Valves Be Safely Removed?Ralf-Harto Hübner, Christoph Ruwwe-Glösenkamp, Jacopo Saccomanno, et al.
Trials|June 27, 2018
Speech-guided breathing retraining in asthma: a randomised controlled crossover trial in real-life outpatient settingsDietrich von Bonin, Sabine D Klein, Jana Würker, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Immune Checkpoint Blockade Combined with AbnobaViscum<sup>®</sup> Therapy Is Linked to Improved Survival in Advanced or Metastatic Non-Small-Cell Lung Cancer Patients: A Registry Study in Accordance with the ESMO Guidance for Reporting Real-World EvidenceFriedemann Schad, Anja Thronicke, Ralf-Dieter Hofheinz, et al.
Journal of Breath Research|May 19, 2026
Feasibility Study on Training Dogs to Detect Lung Cancer: Findings of a Retrospective EvaluationChristian Grah, Shiao Li Oei, Steven Ngandeu Schepanski, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Evidence-Based Complementary and Alternative Medicine : Ecam|May 27, 2020
Health-Related Quality of Life in Patients with Lung Cancer Applying Integrative Oncology Concepts in a Certified Cancer CentreAnja Thronicke, Phillipp von Trott, Matthias Kröz, et al.
The Thoracic and Cardiovascular Surgeon|February 18, 2021
Is Adjuvant Radiochemotherapy Always Mandatory in Patients with Resected N2 Non-Small Cell Lung Cancer?Samantha Taber, Joachim Pfannschmidt, Torsten T Bauer, et al.
International Journal of Molecular Sciences|May 7, 2025
Combined Immune Checkpoint Blockade and Helixor<sup>®</sup> Therapy in Oncology: Real-World Tolerability and Subgroup Survival (ESMO GROW)Anja Thronicke, Patricia Grabowski, Juliane Roos, et al.
Plos One|August 28, 2018
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysisFriedemann Schad, Anja Thronicke, Megan L Steele, et al.
Plos One|August 16, 2022
Correction: Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysisFriedemann Schad, Anja Thronicke, Megan L Steele, et al.
Plos One|July 28, 2020
Cost-effectiveness of real-world administration of chemotherapy and add-on Viscum album L. therapy compared to chemotherapy in the treatment of stage IV NSCLC patientsAnja Thronicke, Thomas Reinhold, Philipp von Trott, et al.
Respiration; International Review of Thoracic Diseases|March 23, 2020
Endoscopic Lung Volume Reduction: Can Endobronchial Valves Be Safely Removed?Ralf-Harto Hübner, Christoph Ruwwe-Glösenkamp, Jacopo Saccomanno, et al.
Trials|June 27, 2018
Speech-guided breathing retraining in asthma: a randomised controlled crossover trial in real-life outpatient settingsDietrich von Bonin, Sabine D Klein, Jana Würker, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Immune Checkpoint Blockade Combined with AbnobaViscum<sup>®</sup> Therapy Is Linked to Improved Survival in Advanced or Metastatic Non-Small-Cell Lung Cancer Patients: A Registry Study in Accordance with the ESMO Guidance for Reporting Real-World EvidenceFriedemann Schad, Anja Thronicke, Ralf-Dieter Hofheinz, et al.
Journal of Breath Research|May 19, 2026
Feasibility Study on Training Dogs to Detect Lung Cancer: Findings of a Retrospective EvaluationChristian Grah, Shiao Li Oei, Steven Ngandeu Schepanski, et al.
Pageof 5